[Risk Assessment of Hematologic Malignancy Treatment of the Elderly].
Gan To Kagaku Ryoho
; 45(1): 16-19, 2018 Jan.
Article
en Ja
| MEDLINE
| ID: mdl-29362299
ABSTRACT
Along with the aging society in Japan, the number ofelderly cancer patients is increasing, and hematological malignancy is no exception. Treatment ofhematological malignancy is mainly chemotherapy and furthermore it is necessary to keep its dose intensity. In the elderly, adverse events may be strong due to deterioration oforgan function, comorbidity, etc., and it is difficult for individual differences to decide chemotherapy regimen and dose. Geriatric assessment(GA)used in the field of geriatric medicine is reported to be useful for risk assessment of chemotherapy. The usefulness of GA is also shown in hematological malignancy. In non-Hodgkin's lymphoma, attempts have been made to determine the treatment method by stratifying the risk using the results of GA.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Hematológicas
/
Antineoplásicos
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Aged80
/
Humans
Idioma:
Ja
Año:
2018
Tipo del documento:
Article